摘要 :
This report identifies and summarizes evidence from full reports of empirical211 studies published from 1966 to 1996 on the cost of care and economic impact of 211 chronic headache. Of 400 citations identified, 126 met initial scr...
展开
This report identifies and summarizes evidence from full reports of empirical211 studies published from 1966 to 1996 on the cost of care and economic impact of 211 chronic headache. Of 400 citations identified, 126 met initial screening and 35 211 met all criteria and were included in this review. Findings are presented in the 211 following areas: (1) utilization of health care resources, including provider 211 consultation, predictors of receiving a headache diagnosis, use of the emergency 211 department, and hospitalization; (2) pharmaceuticals use, covering prescription 211 vs. nonprescription drugs, preventive medications, frequency of medication use, 211 and the effect of sumatriptan on utilization; (3) nonpharmacological therapy; and 211 (4) work loss. The report concludes that chronic headache sufferers represent a 211 diverse population which is difficult to study. Population-based studies suggest 211 that many headache sufferers do not seek medical care or use prescription drugs 211 for their headaches. Studies conducted among headache patient in clinical 211 settings suggest that these patients have more severe headache symptoms, use more 211 prescription drugs, and are heavier users of medical resources. Data from both 211 types of studies must be considered if the comprehensive cost of chronic headache 211 is to be estimated.
收起
摘要 :
Objective: To (1) examine prescribing patterns of migraine-specific abortive medication among new users and non-users of migraine preventive therapy and (2) determine if treatment with a migraine preventive agent influences the ut...
展开
Objective: To (1) examine prescribing patterns of migraine-specific abortive medication among new users and non-users of migraine preventive therapy and (2) determine if treatment with a migraine preventive agent influences the utilization of migraine-specific abortive agents.
收起
摘要 :
A randomized, placebo-controlled clinical trial is being conducted to evaluate the effectiveness of propranolol, topiramate, and amitriptyline as treatments for chronic post-traumatic headaches secondary to combat-related mild hea...
展开
A randomized, placebo-controlled clinical trial is being conducted to evaluate the effectiveness of propranolol, topiramate, and amitriptyline as treatments for chronic post-traumatic headaches secondary to combat-related mild head injury. The study is in the first of three years. 34 of 240 subjects have been enrolled. The study medications are well tolerated. Study subjects had a 60% decrease in headache frequency after 3 months of treatment. There is insufficient data at this time to draw conclusions about the efficacy of specific study medications. The study remains open to enrollment.
收起
摘要 :
Headache was the principal cause of an estimated 18,341,923 visits to office-based physicians during 1977-78. Headache was the seventh most frequent symptomatic reason for visits given by patients. The estimates in this report are...
展开
Headache was the principal cause of an estimated 18,341,923 visits to office-based physicians during 1977-78. Headache was the seventh most frequent symptomatic reason for visits given by patients. The estimates in this report are based on data collected in the National Ambulatory Medical Care Survey (NAMCS), a probability sample survey conducted yearly by the Division of Health Care Statistics of the National Center for Health Statistics. Since the estimates presented in this report are based on a sample rather than on the entire universe of office-based physicians, the data are subject to sampling variability.
收起
摘要 :
Headache is often associated with physical trauma and psychological stress. The aim of this study is to evaluate the impact of headache on personnel deployed in war zones and to identify factors associated with return to duty (RTD...
展开
Headache is often associated with physical trauma and psychological stress. The aim of this study is to evaluate the impact of headache on personnel deployed in war zones and to identify factors associated with return to duty (RTD). Outcome data were prospectively collected on 985 personnel medically evacuated out of Operations Iraqi and Enduring Freedom for a primary diagnosis of headache between 2004 and 2009. Electronic medical records were reviewed to examine clinical and treatment patterns and the effect that myriad factors had on RTD.
收起
摘要 :
A randomized, double-blinded, placebo-controlled clinical trial was conducted to evaluate the effectiveness of propranolol, topiramate, and amitriptyline as treatments for chronic post-traumatic headaches secondary to combat-relat...
展开
A randomized, double-blinded, placebo-controlled clinical trial was conducted to evaluate the effectiveness of propranolol, topiramate, and amitriptyline as treatments for chronic post-traumatic headaches secondary to combat-related mild head injury. Over a 3-year period 305 soldiers with chronic PTH were screened and 64 were enrolled, falling short of the enrollment target of 240 subjects. 39 (61%) had evaluable data after drug titration and 34 (53%) completed the 3-month treatment period. Discontinuation rates ranged from 39% for topiramate to 53% for amitriptyline but were not significantly different between treatment arms. Monthly headache days decreased from 12.2 at baseline to 7.9 during the final month in all subjects (-36%, p=0.0001), 16.7 to 8.7 in the placebo arm (-48%, p=0.012), 11.7 to 6.1 in the amitriptyline arm (-41%, p=0.0005), 14.0 to 8.3 in the propranolol arm (-41%, p=0.10), and 9.3 to 8.8 in the topiramate arm (-5%, p=0.80). Mean MIDAS scores decreased from 71 at baseline to 31 at the final visit among all subjects (p=0.0001) and significantly declined in the placebo, topiramate, and propranolol arms. There were no significant differences between placebo and any treatment. PTSD symptom checklist scores significantly declined in the topiramate arm. This study is limited by the small number of subjects, high response rate in the placebo arm, and relatively low subject completion rate. The study is closed.
收起
摘要 :
Chronic pain is the most disabling and expensive nonmalignant illness in theindustrialized world. A 1986 Lou Harris poll found that most the common reason people missed work was due to head pain. One of the most common sources of ...
展开
Chronic pain is the most disabling and expensive nonmalignant illness in theindustrialized world. A 1986 Lou Harris poll found that most the common reason people missed work was due to head pain. One of the most common sources of chronic head pain disorders are temporomandibular disorders (TMD). It is estimated that 25-73% of the industrialized population will suffer from a TMD at sometime during their life. Temporomandibular disorders are a group of musculoskeletal problems that involve the masticatory muscles and/or the temporomandibular joint (TMJ). Treatment is usually palliative in nature rather than curative and generally involves multiple therapies. One of the most common therapies prescribed by dentists for TMD is an intraoral occlusal appliance.
收起
